Macular Degeneration Trial, Recruiting

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

• People aged 50 years or older
• People who have reticular pseudodrusen (a type of deposit in the eye) caused by age-related macular degeneration (AMD)
• People whose best vision (with glasses or contacts if needed) falls within a certain range — roughly from normal vision down to significantly reduced vision (20/20 to 20/400)
• People with clear eyes — meaning no cloudiness or other issues blocking the view inside the eye
• People who are able to give their agreement to participate and attend all required appointments during the study

Who may not be able to join:

• People who have a condition called Geographic Atrophy (an advanced form of AMD involving permanent damage to the retina)
• People who have abnormal blood vessel growth in either eye (a condition called choroidal neovascularization)
• People who have previously received any treatment for AMD, except for antioxidant supplements
• People with cloudiness of the cornea, cataracts, or bleeding inside the eye that could block the laser doctor's view of the target area
• People with a specific eye condition where the natural lens has been removed and gel from inside the eye has moved to the front of the eye
• People who have glaucoma caused by abnormal blood vessel growth
• People who have glaucoma caused by a structural problem present from birth
• People with certain structural issues in the drainage angle of the eye (confirm with trial site)
• People with significant swelling or cloudiness of the cornea that blocks a detailed view of the eye's drainage angle
• People with glaucoma caused by active inflammation inside the eye
• People with any other eye condition that could worsen during the study and affect vision assessment
• People taking any eye or general medication known to be harmful to the lens, retina, or optic nerve
• People with inflammation inside the eye (uveitis) without a known cause, or caused by an autoimmune condition
• People who have had eye surgery within 3 months before joining the study
• People who have previously had laser treatment directed at the central part of the retina (the macula)
• People who have previously had surgery inside the eye to remove the gel (vitrectomy), glaucoma drainage surgery, corneal transplant, or surgery to repair a detached retina
• People who have previously had radiation treatment in or around the eye area in either eye
• People who have taken part in a study using an experimental treatment within 60 days before joining
• Women who could become pregnant — unless they have been postmenopausal for at least 1 year, had a sterilisation procedure at least 6 weeks ago, or are using highly effective contraception during the study treatment period
• People who have taken part in a study involving an experimental drug, biological treatment, or medical device within 6 months before the start of the study (note: studies involving only over-the-counter vitamins, supplements, or diet changes are not considered exclusionary)

Important: Always verify eligibility with the trial site directly before applying.